Effects of Rapamycin on the Differentiation and Function of Macrophages In Vitro

Agricultural Sciences in China

Volumn 8, Issue 5, 2009, Pages 620-627

  SHEN, Hong ^a,b   WU, Guo juan ^a   LIU, Guang wei ^b   MA, Hai xia ^b   LIAO, An yan ^c   ZHAO, Yong ^b  

^a BEIJING UNIVERSITY OF AGRICULTURE   (China)

^b INSTITUTE OF ZOOLOGY   (China)

^c BEIJING UNIVERSITY OF CHINESE MEDICINE THIRD AFFILIATED HOSPITAL   (China)

Author keywords

differentiation; function; macrophages; rapamycin

Indexed keywords

EID: 65649115420     PISSN: 16712927     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1671-2927(08)60254-0     Document Type: Article

References (25)

1. Adams D.O., and Hamilton T.A. The cell biology of macrophage activation. Annual Review Immunology 2 (1984) 283-318
2. Aoki M., Blazek E., and Vogt P. A role of the kinase mTOR in cellular transformation induced by the oncoproteins P3k and Akt. Proceedings of the National Academy of Sciences of the USA 98 (2001) 136-141
3. Butzal M., Loges S., Schweizer M., Fischer U., Gehling U.M., Hossfeld D.K., and Fiedler W. Rapamycin inhibits proliferation and differentiation of human endothelial progenitor cells in vitro. Experimental Cell Research 300 (2004) 65-71
4. Celada A., and Nathan C. Macrophage activation revisited. Immunology Today 15 (1994) 100-102
5. Cella M., Sallusto F., and Lanzavecchia A. Origin, maturation and antigen presenting function of dendritic cells. Current Opinion Immunology 9 (1997) 10-16
6. Chapuis F., Rosenzwajg M., Yagello M., Ekman M., Biberfeld P., and Gluckman J.C. Differentiation of human dendritic cells from monocytes in vitro. The Journal of Immunology 27 (1977) 431-441
7. Dumont F.J., Staruch M.J., Koprak S.L., Melino M.R., and Sigal N.H. Distinct mechanisms of suppression of murine T cell activation by the related macrolides FK-506 and rapamycin. The Journal of Immunology 144 (1990) 251-258
8. El-Sabrout R., Delaney V., Butt F., Qadir M., Hanson P., and Tuteja S. Improved freedom from rejection after a loading dose of sirolimus. Transplantation 75 (2003) 86-90
9. Faust N., Huber M.C., Sippel A.E., and Bonifer C. Different macrophage populations develop from embryonic/fetal and adult hematopoietic tissues. Experimental Hematology 25 (1997) 432-444
10. Gordon S., Fraser I., Nath D., Hughes D., and Clarke S. Macrophages in tissues and in vitro. Current Opinion Immunology 4 (1992) 25-32
11. Gordon S., and Taylor P.R. Monocyte and macrophage heterogeneity. Nature Reviews Immunology 5 (2005) 953-964
12. Guba M., von Breitenbuch P., Steinbauer M., Koehl G., Flegel S., Hornung M., Bruns C.J., Zuelke C., Farkas S., Anthuber M., Jauch K.W., and Geissler E.K. Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor. Natural Medicine 8 (2002) 128-135
13. Lee J.K., Kim J.K., Lee Y.R., Kim H.S., Im S.A., Kim K., and Lee C.K. Exposure to chemokines during maturation modulates antigen presenting cell function of mature macrophages. Cellular Immunology 234 (2005) 1-8
14. Khalili H., Deshpande R., and Chang M.Y. The defective antigen-presenting activity of murine fetal macrophage cell lines. Immunology 92 (1997) 487-493
15. Lee K.K., Kang J.K., Hofmeister R., Durum S.K., and Han S.S. Generation of macrophages from early T progenitors in vitro. The Journal of Immunology 166 (2001) 5964-5969
16. Meißner U., Jüttner S., Röllinghoff M., and Gessner A. Cyclosporin A-mediated killing of Leishmania major by macrophages is independent of reactive nitrogen and endogenous TNF-a and is not inhibited by IL-10 and 13. Parasitology Research 89 (2003) 221-227
17. Podsypanina K., Lee R.T., Politis C., Hennessy I., Crane A., and Puc J. An inhibitor of mTOR reduces neoplasia and normalizes p70/S6 kinase activity in Pten +/-mice. Proceedings of the National Academy of Sciences of the USA 98 (2001) 10320-10325
18. Rutherford M.S., Witsell A., and Schook L.B. Mechanisms generating functionally heterogeneous macrophages: chaos revisited. Journal of Leukocyte Biology 53 (1993) 602-618
19. Sallusto P., and Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor a. The Journal of Experimental Medicine 179 (1994) 1109-1118
20. Schaffner A. Therapeutic concentrations of glucocorticoids suppress the antimicrobial activity of human macrophages without impairing their responsiveness to gamma interferon. Journal of Clinical Investment 76 (1985) 1755-1764
21. Sehgal S.N. Rapamune (RAPA, rapamycin, sirolimus): mechanism of action immunosuppressive effect results from blockade of signal transduction and inhibition of cell cycle progression. Clinical Biochemistry 31 (1998) 335-340
22. Smith W., Feldmann M., and Londei M. Human macrophages induced in vitro by macrophage colony-stimulating factor are deficient in IL-12 production. European Journal of Immunology 28 (1998) 2498-2507
23. Stout R.D., and Suttles J. Functional plasticity of macrophages: reversible adaptation to changing microenvironments. Journal of Leukocyte Biology 76 (2004) 509-513
24. Vignot S., Faivre S., Aguirre D., and Raymond E. mTOR-targeted therapy of cancer with rapamycin derivatives. Annals of Oncology 16 (2005) 525-537
25. Werb Z. Biochemical actions of glucocorticoids on macrophages in culture. Specific inhibition of elastase, collagenase, and plasminogen activator secretion and effects on other metabolic functions. Journal of Experimental Medicine 147 (1978) 1695-1712